Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2021 | Story Leonie Bolleurs | Photo Supplied
The Department of Engineering Sciences (EnSci) – under the leadership of Dr Abdolhossein Naghizadeh – is heading a collaboration of scientists to create a green concrete that will reduce the impact of cement on the environment.

Conventional cement production is responsible for more than 6% of the overall carbon emissions in the world, which ultimately affects global warming.

The Department of Engineering Sciences (EnSci) at the University of the Free State (UFS) – under the leadership of Dr Abdolhossein Naghizadeh – is heading a collaboration of scientists from universities in South Africa and abroad to create a green concrete that will reduce the impact of cement on the environment.

This product has the potential to be used as an alternative to conventional concrete in large-scale constructions such as residential buildings and infrastructure, as well as small-scale constructions such a pavements and brickworks. 

Dr Nagizadeh, whose passion is cement and green concrete, says the idea of eco-friendly concrete was considered by European researchers a few years ago; however, this technology is still in its initial stages and has not been researched and employed at industrial scale yet. He believes that it is due to the complexity of the preparation process, and the relatively aggressive chemicals used in green concrete mixtures.

Expertise and equipment 

With his knowledge and experience of the product, Dr Naghizadeh – who joined EnSci in 2020 – has been appointed project leader of a collaborative group of scientists from the Universities of Johannesburg, KwaZulu-Natal, Yaoundé in Cameroon, and the Erzurum Technical University in Turkey.  

“Since there are only a limited number of researchers in this field, EnSci is benefiting from the expertise of this international collaboration. The proficiency of this group of scientists are keeping the project current, based on the latest findings in the research area,” says Louis Lagrange, Head of the Department of Engineering Sciences. 

Based on this new capacity, the department decided to establish and equip a new laboratory facility dedicated to cement and concrete research, with a specific current focus on green concrete. 

In this laboratory, they want to create formulations of green concrete, based on user-friendly materials. Furthermore, they aim to simplify the preparation and mixing process. “This can introduce a more eco-friendly, desirable product that can easily be employed extensively in the construction industry,” says Lagrange.

Benefits and other advantages

Besides its ability to reduce the impact on the environment through reduced carbon emissions, the product is also described to perform at equal or even superior strength and durability compared to conventional concrete, with potentially substantial environmental and economic benefits. 

This product is also primarily made from waste materials or industrial by-products. Dr Naghizadeh explains it as follows: “Normal concrete consists of conventional (Portland) cement, sand, stone and water, while in green concrete the conventional cement part of the concrete mix is replaced by industrial wastes or by-products and alkali solutions. These alternative materials are mostly aluminosilicate materials such as fly ash (residue from coal burning process in power plants) and slag (waste material from iron extraction processes).”

“Using these waste substances as binding material in green concrete can, apart from the environmental benefits, also reduce waste and contribute to the circular economy. Annually, more than 36 million tons of fly ash are produced in South Africa alone, of which more than 90% is deposited at landfill sites. Reuse of these waste materials will moderate the related waste deposition issues, such as air and groundwater pollution.”

Production of green concrete

Currently, green concrete is mostly produced in two parts: a solid raw material and an alkali activation solution. With their project, the research group wants to develop green concrete in a powdered form, to be mixed with water, instead of a chemical. Dr Nagizadeh estimates that the construction industry will be able to benefit from their work in about two years’ time when they will have a user-friendly green concrete product ready. 

Apart from putting an eco-friendlier concrete on the market, this project is also establishing a brand-new research niche in the UFS Department of Engineering Sciences. According to Lagrange, this research has the ability to attract postgraduate students and other researchers. He is also looking forward to the international academic recognition that EnSci will receive through published articles in leading international journals, and the participation of researchers in accredited conferences arising from this project. 

Lagrange is pleased that the project is establishing EnSci as a research player of note in the engineering field, specifically in the green engineering field. 

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept